1.34
+0.01(+0.75%)
Currency In USD
Address
121 South Orange Avenue
Orlando, FL 32801
United States of America
Phone
407 377 6695
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
October 01, 2021
| Name | Title | Pay | Year Born |
| Mr. Gareth Sheridan | Chief Executive Officer | 155,000 | 1990 |
| Mr. Michael Myer | President of Pocono Pharmaceutical | 40,600 | 1984 |
| Mr. Gerald Goodman | Chief Financial Officer & Chief Accounting Officer | 115,000 | 1948 |
| Mr. Serguei Melnik | Founder, President, Company Secretary & Executive Chairman | 155,000 | 1974 |
| Dr. Alan Smith Ph.D. | Chief Operating Officer & President of 4P Therapeutics | 159,000 | 1966 |
| Dr. Jeffrey Patrick Pharm.D. | Chief Scientific Officer | 0 | 1970 |
| Mr. Tyler Overk | Head of Active Intelligence | 0 | 1984 |
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.